Patent ID: 8501177

Claim:
A method for treating a symptom of X-coupled hypohydrotic ectodermal dysplasia in a patient diagnosed with or suspected of having X-coupled hypohydrotic ectodermal dysplasia comprising administering to the patient a pharmaceutical composition comprising a recombinant fusion protein, which comprises (a) an Fc segment of an immunoglobulin consisting of amino acids 18 to 243 of SEQ ID NO: 6, and (b) an extracellular moiety of Ectodysplasin-A (EDA1) comprising amino acids 266 to 412 of SEQ ID NO: 6, wherein the symptom of X-coupled hypohydrotic ectodermal dysplasia is selected from the group consisting of: missing teeth, abnormal development of teeth, dysfunction or lack of sweat glands, lack of Moebius glands, lack of sebaceous glands, and alopecia.